Research analysts at StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the medical equipment provider’s stock.
Aethlon Medical Price Performance
AEMD opened at $0.40 on Friday. The company’s 50 day simple moving average is $0.40 and its 200-day simple moving average is $0.52. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same period in the prior year, the business earned ($1.30) earnings per share. On average, equities analysts anticipate that Aethlon Medical will post -1.1 EPS for the current fiscal year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
See Also
- Five stocks we like better than Aethlon Medical
- What is the Hang Seng index?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 11/4 – 11/8
- What Are Dividend Challengers?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
